TORONTO, ON, May 28, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) and its wholly owned virtual care platform, Rocket Doctor, are proud to announce that the company has recently been recognized by three of the most prestigious organizations in healthcare innovation: UC Berkeley’s Health Engine, Harvard University, and the AARP AgeTech Accelerator. These distinctions... Read More

VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) announces that it has granted an additional 633,589 restricted share units (“ RSUs ”) and 330,132 stock options (“ Options ”) to continuing employees and consultants of Rocket Doctor Inc., the Company’s wholly-owned subsidiary (see News Release dated April 10, 2025). The Options are each... Read More

Toronto, ON, May 20, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is proud to announce that its virtual care subsidiary, Rocket Doctor Inc., has partnered with Melanoma Canada to help bridge the care gap for individuals identified as at-risk for melanoma and other skin cancers during mobile screening events across the country. Melanoma Canada’s Mole Mobile units,... Read More

RFK Jr. calls for a “revolution” in telehealth and AI to reduce ER visits and improve at-home care. Treatment.com AI and Rocket Doctor applaud the remarks, citing strong alignment with their mission. Rocket Doctor is currently empowering physicians to run their own practices in New York and California, serving Medicaid and Medicare patients in underserved communities. ‏ VANCOUVER, BC, May 15, 2025 (GLOBE NEWSWIRE) --... Read More

Rocket Doctor named Clinical Innovator of the Year at the Innovators Challenge during NEXUS 2025 in New Orleans. Award recognizes Rocket Doctor’s physician-led virtual care model, designed to empower doctors and expand access to care. Platform enables independent physicians to launch and manage their own virtual or hybrid practices with built-in support and AI tools. Selected as winner following a live pitch session judged... Read More

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 10, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“ Treatment ”) is pleased to announce, further to its news release of February 12, 2025, that it has closed the acquisition of 100% of the issued and outstanding securities of Rocket Doctor Inc.... Read More

VANCOUVER, British Columbia, April 10, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“ Treatment ”) is pleased to announce, further to its news release of February 12, 2025, that it has closed the acquisition of 100% of the issued and outstanding securities of Rocket Doctor Inc. (the “ Transaction ”) pursuant to the terms and conditions of a Share Purchase Agreement dated February... Read More

Market for Clinical Decision Support (CDSS) in China is ~US$600 million by 2030 Aiyibotong has installed systems in >200 healthcare institutions in China Aiyibotong and Treatment.com AI both using proprietary artificial intelligence (AI) and Machine Learning (ML) platforms Co-marketing opportunities in China Combining Aiyibotong’s CDSS with Treatment AI's Global Library of Medicine will look to create further differentiation... Read More

●71,000+ Albertans have received care through Rocket Doctor, with 35% of patients residing in communities with populations under 25,000. ‎●A 112% increase in patient visits between 2023 and 2024, demonstrating strong demand for online healthcare solutions. ‎●218% year-over-year growth in new physicians joining the platform, expanding care options across the province. ‎●A 4.4-star rating on Google for Rocket Doctor with over... Read More

Vancouver, British Columbia, March 14, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc . (the “ Company ” or “ Treatment ”) (CSE: TRUE; OTC: TREIF; FFA: 939) announces that, further to its news release dated January 24, 2025, it has extended the term of marketing and investor awareness services provided by i2i Marketing Group, LLC (i2i”) for an additional two (2) months, now expiring on September 23, 2025, in consideration of... Read More

Vancouver, British Columbia, March 13, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “ Company ” or “ Treatment ”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce that further to its news releases dated February 27, 2025 and March 3, 2025, it has closed its previously announced brokered private placement under the Listed Issuer Financing Exemption (the “ Offering ”) with Ventum Capital Corp., (the “Underwriter... Read More

Vancouver, British Columbia, March 03, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “ Company ” or “ Treatment ”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce that due to high demand it has upsized the previously announced brokered private placement of units of the Company (the “ Offering ”) with Ventum Financial Corp., as underwriter to $3.30 million in gross proceeds with a 15% over-allotment option. The... Read More

Vancouver, British Columbia, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “ Company ” or “ Treatment ”) (CSE: TRUE; OTC: TREIF; FFA: 939 ) is pleased to announce that it has entered into an agreement with Ventum Financial Corp., as underwriter (the “ Underwriter ”) and sole bookrunner in connection with a brokered private placement of 6,000,000 units (the “ Units ”) of the Company at a price of C$0.50 per... Read More

Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor’s Approval as an In-Network Provider for New York Medicaid Strengthening Access to Virtual Healthcare Across the State and Collaboration with EngageWell. Approved as an in-network provider for New York Medicaid, covering 6.9 million individuals (35% of the state’s population) Expands Rocket Doctor’s virtual healthcare services... Read More

Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor’s Approval as an In-Network Provider for New York Medicaid Strengthening Access to Virtual Healthcare Across the State and Collaboration with EngageWell. Approved as an in-network provider for New York Medicaid, covering 6.9 million individuals (35% of the state’s population) Expands Rocket Doctor’s virtual healthcare services... Read More

Rocket Doctor partners with new Managed Care Plan serving ~450,000 California Medicaid members Future anticipated additional ARR of ~US$1.2 million Mission to break down barriers to healthcare access Reducing unnecessary ER visits, reducing wait times, timely specialist referrals VANCOUVER, British Columbia, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“ Treatment ”) is... Read More

Vancouver, British Columbia, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939 ) announces that it has entered into a M&A credit facility to fund transaction expenses and closing costs associated with acquisitions such as rocket Doctor. The credit facility is up to $1.5 million at an annual interest rate of 12% and for a term of 18 months. The credit... Read More

Addition of ~[C$1.9] million unaudited ARR SaaS revenues Total Billable Value of Services increased to ~ C$7.1 million, up from C$4.3 million in 2023 Growing Network of over 300 doctors currently supporting up to 20 specialties (inc. GP Services, Women’s Health, Mental Health, Cardiology, Psychiatry, Internal Medicine, Pediatrics), 500,000 patient visits (over 650 per day) Enabling healthcare professionals to build... Read More

Strategic Expansion with Proposed Acquisition of Alea Health Holdings Limited, a UAE based AI company‏ Proprietary Voice Agent using Conversational AI for onboarding and triaging patients‏ Extended geographic reach - entry into the Middle East Healthcare market‏ Advancing Mental Health Support using Alea’s proprietary and AI powered Mental Health Platform to Augment Primary and Specialist Care‏ Enhanced Bench Strength:... Read More

Treatment.com AI announces expanded and updated MES new releases Lead commercial participant at Global/North American Symposium on AI Assessment in Medical Education Further enhancements and solutions set for H2 2024 VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“ Treatment ”) is pleased to announce the launch of its updated Medical Education... Read More

Treatment.com AI announces expanded and updated MES new releases Lead commercial participant at Global/North American Symposium on AI Assessment in Medical Education Further enhancements and solutions set for H2 2024 VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“ Treatment ”) is pleased to announce the launch of its updated Medical Education... Read More

Vancouver, British Columbia, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “ Company ” or “ Treatment ”) (CSE: TRUE; OTC: TREIF; FFA: 939 ) is pleased to announce that, further to its news release dated October 4, 2024, it has closed a non-brokered private placement of 2,138,766 special warrants of the Company (each, a “ Special Warrant ”) at a price of $0.75 per Special Warrant, for aggregate gross proceeds... Read More

Treatment.com AI CEO, Dr. Essam Hamza, is to present live at 11:00 AM ET on Wednesday, October 9, 2024 Vancouver, British Columbia--(Newsfile Corp. - October 1, 2024) - Treatment.com AI Inc. (CSE: TRUE) (OTCQB: TREIF) (FSE: 939) ("Treatment"), a healthcare tech company focused on transforming patient care with AI-driven Clinical insights, is pleased to announce its participation at the upcoming Cantech Letter Investment... Read More

Treatment.com AI CEO, Dr. Essam Hamza, is to present live at 11:00 AM ET on Wednesday, October 9, 2024. VANCOUVER, British Columbia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”), a healthcare tech company focused on transforming patient care with AI-driven Clinical insights, is pleased to announce its participation at the upcoming Cantech Letter Investment... Read More

Treatment.com AI CEO, Dr. Essam Hamza, is to present live at 11:00 AM ET on Wednesday, October 9, 2024. VANCOUVER, British Columbia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc . (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”), a healthcare tech company focused on transforming patient care with AI-driven Clinical insights, is pleased to announce its participation at the upcoming Cantech Letter Investment... Read More

OSCE (Objective Structured Clinical Examination) now adopted in over 80 countries and with upwards of 200k students annually Lead commercial participant at Global/North American Symposium on AI Assessment in Medical Education AI Assessment in Medical Education Symposium New solutions on track for H2 2024 (AI Patient/Doctor in Pocket) VANCOUVER, British Columbia, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE:... Read More

SPRYT has developed an AI receptionist called Asa - Medical Office Assistant (MOA) in your pocket Patients communicate with Asa via standard messaging apps such as WhatsApp and SMS/RCS. No app download required 25% of healthcare spending in the USA stems from administrative tasks such as billing and scheduling. This is over $1Trillion/yr Cost of missed appointments in the US alone is $150 Billion/yr Combining with Treatment... Read More

VANCOUVER, British Columbia, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc . (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“ Treatment ”) is pleased to announce it has signed a Collaborative Agreement with the University Court of the University of Edinburgh (“ University of Edinburgh ”). The University of Edinburgh is looking to utilize Treatment’s proprietary Global Library of Medicine (“GLM”) to jointly build... Read More

VANCOUVER, British Columbia, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“ Company ” or “ Treatment ”), a healthcare tech company transforming patient care with AI-driven clinical insights, endorses the forward thinking emanating from a recent event in Washington comprising 25 of the nation’s leading experts on the appropriate use of artificial intelligence (AI) within... Read More

VANCOUVER, British Columbia, July 31, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“ Company ” or “ Treatment ”), a healthcare tech company transforming patient care with AI-driven clinical insights is excited to announce a new solution, AI Pharmacy Assistant designed to support pharmacists. Pharmacists are playing an increasing role in the provision of clinical decision support... Read More

VANCOUVER, British Columbia, July 31, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“ Company ” or “ Treatment ”), a healthcare tech company transforming patient care with AI-driven clinical insights is excited to announce a new solution, AI Pharmacy Assistant designed to support pharmacists. Pharmacists are playing an increasing role in the provision of clinical decision support... Read More

VANCOUVER, British Columbia, July 24, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”), a healthcare tech company transforming patient care with AI-driven clinical insights is pleased to provide the market with an update on the exercising of the warrants which were issued upon conversion of the special warrants on June 21, 2024. Since the special... Read More

Positive Financial Update New Partnerships Announced - aiXplain/Novus Health GLM - AI Accuracy and Effectiveness in Healthcare Bolstering the Executive, Scientific and Development Team - Dr. Jean Challiner AI Patient and AI Doctor in Your Pocket planned release in H2 VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment AI”)... Read More

VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“ Treatment ”) is pleased to announce it has signed a Collaborative Agreement with Health Care Services International Inc (o/a Novus Health). (“ Novus Health ”) to explore utilization of Treatment’s proprietary Global Library of Medicine (“GLM”) to further enhance Novus Health’s Health Risk Assessment... Read More

VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”), a healthcare tech company transforming patient care with AI-driven clinical insights is pleased to announce the appointment of Richard Atkins as Chief Operating Officer and a member of the executive team. Mr. Atkins brings to the business a successful career with over... Read More

VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”) is excited to announce one of the leading US medical schools has agreed to a contract renewal utilizing Treatment’s Medical Education Suite (“ MES ”). Treatment is also in discussions with a number of other medical and nursing schools, both in the US and... Read More

VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”) is excited to announce two new solutions, (1) AI Patient and (2) AI Doctor in a Pocket, to augment its Medical Education Suite (“ MES ”) designed to educate the next generation of healthcare providers. Treatment’s MES enhances the entire continuum of clinical content... Read More

VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“ Treatment ”) is pleased to announce it has signed a Collaborative Agreement with aiXplain, Inc. (“ aiXplain ”) to enable greater access to Treatment’s proprietary Global Library of Medicine (“GLM”) by contributing to aiXplain’s ever-growing dynamic Artificial Intelligence (AI) marketplace.... Read More

VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”) welcomes Prime Minister Justin Trudeau’s announcement on 7th April, 2024, that the federal government plans to fund $2.4 billion in its upcoming budget towards build capacity in Artificial Intelligence (AI) adoption. The federal government’s announcement indicates an... Read More

VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”) is pleased to announce that the Company has received funding from The National Institute of Health (“ NIH ”) to develop a culturally sensitive AI approach for collecting family medical history. Treatment has partnered with Rush River Research in Minneapolis to... Read More

VANCOUVER, British Columbia, March 20, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce that it’s AI medical information support platform was used in the “Objective Structured Clinical Examination” (“ OSCE ”), a standard clinical exam of diagnostic aptitude at medical and nursing schools, passing the exam with a 92% success rate.... Read More

Vancouver, British Columbia, March 14, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “ Company ” or “ Treatment ”) (CSE: TRUE; OTC: TREIF; FFA: 939 ) is pleased to announce that, further to its news release dated February 16, 2024, it has closed a non-brokered private placement of 6,295,500 special warrants of the Company (each, a “ Special Warrant ”) at a price of $0.40 per Special Warrant, for aggregate gross... Read More

Bolstering the Leadership Team The Global Library of Medicine Passes Milestone of 1000+ Diseases Treatment Provides Platform to Support Healthcare in Nairobi, Kenya VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to provide a general corporate update. Treatment has been working diligently to continue its... Read More

Vancouver, BC, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc . (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce the appointment of Mr. David Worner as Chief Financial Officer of the Company, effective February 5, 2024. Mr. Worner is currently the Chief Executive Officer & Founder of GrowthPath Partners, a transactional accounting & advisory firm that services companies... Read More

VANCOUVER, British Columbia – TheNewswire - October 31, 2023 – Treatment.com International Inc. (CSE:TRUE ) ( OTC:TREIF ) ( Frankfurt:939) (the “Company” or “Treatment”) is pleased to announce that the Company’s Board of Directors have approved a name change to “Treatment.com AI Inc.” The Company’s trading symbol on the Canadian Securities Exchange (“CSE”) shall remain the same. No action is required to be taken by... Read More

VANCOUVER, British Columbia – TheNewswire - October 18, 2023 – Treatment.com International Inc. (CSE:TRUE ) ( OTC:TREIF ) ( Frankfurt:939) (the “Company” or “Treatment”) is pleased to announce the appointment of Dr. Essam Hamza, MD to its Board of Directors and as Chief Executive Officer, effective October 17, 2023. Dr.Hamza will also join the Board on that date. The appointment of Dr. Hamza follows a mandate to appoint a... Read More

Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), is a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions. Treatment’s landmark debut product, the Treatment Digital Health App , has been garnering five-star reviews on both the Apple App Store and the Google Play Store. Users’... Read More

Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions, announces the proceeding of a non-brokered private placement, raising aggregate gross proceeds of up to $1,250,000 in unsecured convertible debentures (the “Private... Read More

Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global healthcare technology company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions. After a successful launch on the Apple App Store, Treatment’s revolutionary symptom assessment tool, Treatment Digital Health App , is now available to millions... Read More

Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global healthcare technology company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions. Today, Treatment announces the global launch of its much-anticipated Treatment Digital Health App, now available in the Apple App Store. The Treatment Digital... Read More

Treatment . com International Inc. (“Treatment” or the “Company”) (CSE: TRUE), (OTC: TREIF), a healthcare AI technology company, has entered into a research project agreement with the University of Minnesota to add more than 220 dermatologic diseases to their proprietary, responsive AI engine known as the Global Library of Medicine (GLM). The addition of these diagnoses will bring another level of accuracy and specificity to... Read More

Treatment.com International Inc. (“Treatment or the (“Company”) (CSE: TRUE • OTC: TREIF • 939.F) is a healthcare technology company with a passion for supporting consumers and health care providers globally with easy, AI-driven solutions. Today Treatment announces the first sale of its Treatment Primary Care Module, powering the next generation of AI-assisted healthcare. Using medically built artificial intelligence, the... Read More

Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global healthcare technology company that has developed a next-generation AI platform to help clinicians and patients around the world make better health decisions. Today, Treatment announces the beta release of its much-anticipated Treatment Digital Health App. This app is powered by Treatment’s proprietary AI engine which... Read More

Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE), (OTC: TREIF), a healthcare AI technology company, has expanded the reach of its Global Library of Medicine (GLM) by adding more members based in Belgium. Treatment’s GLM is the world’s most advanced medical database, and the platform for a new category of tools in global healthcare delivery. The Global Library of Medicine’s consortium of doctors... Read More

Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE • OTC: TREIF • 939.F) is a healthcare technology company with a passion for supporting consumers and health care providers globally with easy, AI-driven solutions. Today, Treatment is announcing its plan to build our groundbreaking global “Medical Metaverse”. The Medical Metaverse will become Treatment’s roadmap for current and future customers.... Read More

Treatment.com International Inc. (“Treatment” or the (“Company”)) (CSE: TRUE • OTC: TREIF • 939.F) is a healthcare technology company with a passion for supporting consumers and health care providers with easy, supportive solutions. The Company’s unique, proprietary Global Library of Medicine (GLM) and AI engine will be leveraged in the development of a unique value-based rewards system. The Treatment tri-level software... Read More